Study drug SRP-3D taken by mouth in healthy adults
Part of Pain clinical trials.
This Phase 1 study tests how SRP-3D taken by mouth behaves in the body and checks safety. It includes healthy adults and may help researchers understand dosing before studying people with illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 55, and you must be healthy enough for study staff to approve
- You agree to follow the study rules, including staying for the confinement period and returning for visits
- You can speak and understand English or Spanish
- Your BMI is between 18.0 and 32.0
- If you can get pregnant, you are not pregnant and agree to reliable birth control; if male, you’re surgically sterile or you agree to birth control
- You must not have major medical problems or abnormal lab test results at screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called HRS-6257 in healthy volunteers. It looks at how the drug works in the body and checks for side effects after one or several doses.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.
This trial tests a new drug, SRK-439, in healthy adults to see how safe it is and how the body processes it. It helps learn the right dose for future studies.
This trial is testing a new medicine called GS3-007a (a dry powder you take mixed with liquid) to see if it's safe in healthy people. If you join, you'll help doctors understand how the body handles the drug and what side effects might occur.
This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.
Hear when a new Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.